ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies

This study has been completed.
Study NCT00077181.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Leukemia
2 Additional conditions recognized in this trial
Hematologic Neoplasms
3 More general conditions related to this trial
Hematologic Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
4 Interventions listed in this trial
cytarabine
triapine
5 More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
6 Sponsors listed in this trial
University of Chicago
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers